An integrative analysis of genomic data could establish ZNF217 as a prognostic and targetable marker in LD-type ICC, and its interactions could be involved in the poor prognosis of patients with LD-type ICC. This evidence concerns the gene ZNF217 and intrahepatic cholangiocarcinoma.